Seeds Capital

adeno-associated virus, biotech startups, Boehringer Ingelheim Venture Fund, cardiac disease, cardiomyopathy, EDBI, evx ventures, gene therapy, healthtech, heart muscle, Investments, News, nuevocor, preclinical development, Seeds Capital, Singapore Startups, Startups, target discovery, xora innovation

Singapore biotech firm that treats heart disease nets $24m in series A money

Nuevocor will use the fresh funds for the preclinical development of its gene therapy program for patients suffering from dilated…